ALEMBIC
Back to Income Statement
|
ALEMBIC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹222 Cr | ₹157 Cr | ₹127 Cr | ₹78 Cr | ₹74 Cr |
What is the latest Revenue of ALEMBIC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹222 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹127 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | ₹74 Cr |
How is Revenue of ALEMBIC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹222 Cr | 40.89 | |
| Mar2024 | ₹157 Cr | 23.77 | |
| Mar2023 | ₹127 Cr | 62.68 | |
| Mar2022 | ₹78 Cr | 6.40 | |
| Mar2021 | ₹74 Cr | - | |
Compare Revenue of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹2,457.1 Cr | -3.6% | 0.7% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -3.6% |
0.7% |
-10% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses